ReviewJournal of Brown hospital medicine2025
Microangiopathic Hemolytic Anemia in Pregnancy.
Review in Journal of Brown hospital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Disseminated intravascular coagulation secondary to postpartum hemorrhage complicated with autoimmune hemolytic anemia: A case report.The Journal of international medical research · 2026Article
- Multidisciplinary management of concurrent postpartum eclampsia, HELLP syndrome, ruptured hepatic subcapsular hematoma, and atypical hemolytic uremic syndrome: a case report.BMC pregnancy and childbirth · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microangiopathic hemolytic anemia (MAHA) in pregnancy is a rare but life-threatening condition with diverse etiologies. Differentiating pregnancy-related thrombotic microangiopathies (TMAs), such as thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome, disseminated intravascular coagulation (DIC), and hemolysis, elevated liver enzymes, low platelets (HELLP), is critical for timely intervention. This review explores the pathophysiology, diagnostic challenges, and management strategies for MAHA in pregnancy through a patient case. It offers a comprehensive overview of the disease mechanisms, distinguishing diagnostic criteria, and current treatment approaches to aid clinicians in recognizing and managing these complex conditions effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.